Corbus Pharmaceuticals Inc.
CRBP | NASDAQ
$7.75
+$0.10 (+1.31%)
Sep 22, 2026, 12:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -58.01M | -22.97M | -20.56M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M | -16.07M |
Depreciation & Amortization | 100K | 49K | -439K | 50K | 53K | 81K | 146K | 102.31K | 282K | 151.69K | 147.58K | 153K | 158.34K | 181.87K | 374.22K | 190.8K | 192.08K | 195.72K | 375.15K | 307.98K | 420.94K | 424.55K |
Stock-Based Compensation | 3.72M | 1.92M | 1.43M | 1.58M | 1.56M | 1.71M | 1.63M | 2.24M | 1.29M | 982K | 799.18K | 821K | 823.62K | 1.03M | 1.27M | 1.35M | 1.51M | 1.59M | 1.79M | 2.6M | 2.51M | 2.58M |
Other Working Capital | -3.48M | -2.44M | 4.4M | 7.44M | -53K | -316K | -4.23M | -3.98M | 1.38M | -355.71K | 2.49M | -1.36M | -137.54K | 2.27M | 982.75K | 799.64K | -494.29K | -4.52M | -4.06M | -1.21M | -1.57M | -4.52M |
Other Non-Cash Items | -478K | -262K | -191K | -3K | -675K | -238K | 992K | -476.31K | -1.9M | 266.6K | 76.88K | 72K | 778.56K | -2.14K | -182.63K | 11.14K | 801.12K | 988.86K | 712.02K | 1.19M | 130.84K | 106.86K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -535K | -4.31M | 3.84M | 6.16M | 122K | -1M | -2.55M | -2.03M | 1.38M | -1.49M | 988.88K | 1.83M | 46.67K | 1.42M | 1.96M | -10.79K | -1.49M | -3.95M | -2.32M | -1.07M | -3.45M | -8.86M |
Operating Cash Flow | -55.2M | -25.57M | -15.92M | -15.55M | -16.6M | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M | -6.01M | -7.18M | -7.8M | -15.11M | -7.45M | -7.25M | -12.23M | -10.62M | -9.7M | 856.95K | -17.53M | -21.81M |
Capital Expenditures | -12K | -6K | -7K | n/a | n/a | n/a | n/a | n/a | n/a | -2 | n/a | n/a | 5 | n/a | -5 | n/a | n/a | -13.45K | -54.18K | n/a | 1 | 5 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.2K | n/a | 3.8K | 2.6K |
Purchase of Investments | -19.42M | -10.73M | -90.02M | -17.84M | -17.62M | -37.61M | -11.24M | -38.84M | -24.83M | -105.9M | -3.33M | -6.63M | -10.62M | -13.31M | 2.4M | -22.37M | -59.9M | -6.47M | -10M | -6.74M | -13.1M | -57.43M |
Sales Maturities Of Investments | 60.15M | 33.19M | 32.88M | 37.48M | 35.37M | 55.73M | 19.97M | 23.47M | 8.39M | 7.66M | 13.72M | 17.52M | 19.43M | 18.86M | 9.38M | 16.4M | 41.19M | 49.45M | 6.86M | 7.02M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.1K | n/a | n/a | 1.3K | n/a | n/a |
Investing Cash Flow | 40.72M | 22.46M | -57.15M | 19.64M | 17.74M | 18.12M | 8.73M | -15.37M | -16.44M | -98.24M | 10.39M | 10.9M | 8.81M | 5.55M | 11.78M | -5.97M | -18.7M | 42.96M | -3.18M | 284.1K | -13.1M | -57.42M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.9M | -2.15M | -2.32M | -1.83M | -741K | -152.1K | -150.07K | 234.32K | -110.7K | -330.11K | -327.13K | 767.94K | -102.69K | -305.59K | -301.88K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.12M | n/a | -73.84K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 9.08M | n/a | 74.58M | 2.85M | n/a | n/a | -13K | 25.04M | 34.97M | 106.58M | -1.9M | -821K | 17.69K | -113.01K | 234.32K | -110.7K | -330.11K | -327.13K | 767.94K | -102.69K | -255.59K | 60.41M |
Net Cash Flow | -5.41M | -3.12M | 1.51M | 6.94M | 1.14M | 1.7M | -2.23M | -4.26M | 9.58M | 471.91K | 2.47M | 2.9M | 1.02M | -9.68M | 4.56M | -13.33M | -31.26M | 32.02M | -12.11M | 1.04M | -30.88M | -18.82M |
Free Cash Flow | -55.21M | -25.58M | -15.93M | -15.55M | -16.6M | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M | -6.01M | -7.18M | -7.8M | -15.11M | -7.45M | -7.25M | -12.23M | -10.63M | -9.76M | 856.95K | -17.53M | -21.81M |
Adj. Free Cash Flow | -58.93M | -27.49M | -17.36M | -17.13M | -18.16M | -18.14M | -12.57M | -16.19M | -10.23M | -8.95M | -6.81M | -8M | -8.62M | -16.14M | -8.72M | -8.59M | -13.74M | -12.22M | -11.55M | -1.74M | -20.04M | -24.39M |
Maintenance CapEx | -12K | -6K | -7K | n/a | n/a | n/a | n/a | n/a | n/a | -2 | n/a | n/a | 5 | n/a | -5 | n/a | n/a | -13.45K | -54.18K | n/a | 1 | 5 |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -55.21M | -25.58M | -15.93M | -15.55M | -16.6M | -16.42M | -10.94M | -13.94M | -8.94M | -7.97M | -6.01M | -7.18M | -7.8M | -15.11M | -7.45M | -7.25M | -12.23M | -10.63M | -9.76M | 856.95K | -17.53M | -21.81M |
Add to Watchlist
Select watchlists to add or remove CRBP